ented ▁to ▁genom ic ▁sequ encing ▁and ▁follow - up ▁coun sel ing ▁ ▁the ▁Est onian ▁Gen ome ▁Project , ▁which ▁sequ enced ▁ 5 2 , 0 0 0 ▁Est oni ans ▁ ▁Ch alleng es ▁As ▁personal ised ▁medicine ▁is ▁pract iced ▁more ▁widely , ▁a ▁number ▁of ▁challeng es ▁arise . ▁The ▁current ▁approaches ▁to ▁intellectual ▁property ▁rights , ▁re imb urs ement ▁policies , ▁patient ▁priv acy ▁and ▁confident ial ity ▁as ▁well ▁as ▁regul atory ▁o vers ight ▁will ▁have ▁to ▁be ▁re defined ▁and ▁rest ruct ured ▁to ▁accommod ate ▁the ▁changes ▁personal ised ▁medicine ▁will ▁bring ▁to ▁health care . ▁Furthermore , ▁the ▁analysis ▁of ▁acquired ▁di agnostic ▁data ▁is ▁a ▁recent ▁challenge ▁of ▁personal ized ▁medicine ▁and ▁its ▁ad option . ▁For ▁example , ▁gen etic ▁data ▁obtained ▁from ▁next - gener ation ▁sequ encing ▁requires ▁computer - int ensive ▁data ▁processing ▁prior ▁to ▁its ▁analysis . ▁In ▁the ▁future , ▁ade qu ate ▁tools ▁will ▁be ▁required ▁to ▁acceler ate ▁the ▁ad option ▁of ▁personal ised ▁medicine ▁to ▁further ▁fields ▁of ▁medicine , ▁which ▁requires ▁the ▁inter dis cipl inary ▁co operation ▁of ▁exper ts ▁from ▁specific ▁fields ▁of ▁research , ▁such ▁as ▁medicine , ▁clin ical ▁on col ogy , ▁bi ology , ▁and ▁artificial ▁intelligence . ▁ ▁Reg ul atory ▁o vers ight ▁The ▁F DA ▁has ▁already ▁started ▁to ▁take ▁initi atives ▁to ▁integrate ▁personal ised ▁medicine ▁into ▁their ▁regul atory ▁policies . ▁An ▁F DA ▁report ▁in ▁October ▁